Rebecca Hall Will Become Hikma Pharmaceuticals CFO
Hikma Pharmaceuticals will appoint a new finance chief in Q1 2027 to oversee global operations.
Updated on Sept. 24, 2026 in Healthcare
Rebecca Hall, the current CFO at ViiV Healthcare, will join Hikma Pharmaceuticals as its new chief financial officer in the first quarter of 2027. She will also join the company's board as an executive director upon her appointment.
Why it matters
The appointment marks a leadership transition for the manufacturer, which employs 9,500 people across its global operations. Current CFO Khalid Nabilsi will move into a regional executive leadership role following the change.
Incoming CFO Rebecca Hall joins from ViiV Healthcare, a firm that generated nearly £8 billion in revenue during 2025. She brings experience from her 14-year tenure at GSK and her current leadership role at the ViiV business unit.
The players
Rebecca Hall
An experienced finance executive who previously spent 14 years at GSK and currently serves as senior vice-president and CFO at ViiV Healthcare.
Hikma Pharmaceuticals
A global pharmaceutical company with 9,500 employees that operates across North America, Europe, the Middle East, and North Africa.
Khalid Nabilsi
The departing Hikma Pharmaceuticals CFO who will transition into a new role as deputy chief executive for North America and Europe.
ViiV Healthcare
A global specialist HIV company majority-owned by GSK that generated nearly £8 billion in revenue in 2025.
Areb Kurdi
The current acting chief financial officer who will continue overseeing financial operations until the new appointment takes effect.
The details
Rebecca Hall is set to take over the financial helm from acting CFO Areb Kurdi, who will remain in the role until the transition is complete. Khalid Nabilsi, who is stepping down from the CFO position on December 31, 2026, will transition into a new capacity as deputy chief executive for North America and Europe. This shift reorganizes the company's regional management structure alongside its top-level financial oversight.
Timeline
• Khalid Nabilsi will step down as chief financial officer on December 31, 2026.
• Rebecca Hall will join Hikma Pharmaceuticals in the first quarter of 2027.
Market Landscape
This change follows a pattern set by the 2018 move of Rebecca Hall to ViiV Healthcare, marking another key leadership rotation in her career. Executive transitions of this nature often signal a shift in a firm's capital allocation and regional growth strategies.
Operators should monitor upcoming leadership shifts for indicators of future financial priorities or changes in regional investment focus. Professional service providers and B2B vendors may see new reporting protocols once the incoming CFO assumes the role in 2027.
The takeaway
Leadership appointments provide key signals regarding a company's regional and financial priorities for the coming years. Keep a watchful eye on public disclosures in early 2027 for changes in how the organization reports regional growth in North America and Europe.
Further reading
For broader trends in industry leadership and financial management, see the Healthcare section.
